CHRNA7 and Alzheimer disease: Of note, the neuroprotective effect of STI-1 is not limited to ischemic damage, as it was also observed in Alzheimer disease (AD) where STI-1 can block Amyloid β (Aβ) toxicity by binding to PrPC and eliciting neuroprotection through α7nAchR [112].